Curis Inc.

11.37+0.5500+5.08%Vol 1.77M1Y Perf 1 594.03%
Apr 13th, 2021 16:00 DELAYED
BID11.21 ASK11.49
Open10.49 Previous Close10.82
Pre-Market- After-Market-
 - -  - -%
Target Price
13.75 
Analyst Rating
— 0.00
Potential %
20.93 
Finscreener Ranking
★★★★+ —    55.62
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★ —    57.09
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     56.29
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap1.04B 
Earnings Rating
Buy
Price Range Ratio 52W %
83.78 
Earnings Date
11th May 2021

Today's Price Range

10.4111.50

52W Range

0.680013.44

5 Year PE Ratio Range

-2.50-2.90

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
-7.68%
1 Month
-0.92%
3 Months
2.66%
6 Months
751.97%
1 Year
1 594.03%
3 Years
254.75%
5 Years
22.95%
10 Years
-43.05%

TickerPriceChg.Chg.%
CRIS11.370.55005.08
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Financial StrengthValueIndustryS&P 500US Markets
17.00
17.10
0.04
0.06
-4.90
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
95.00
-229.00
-227.70
-450.20
-
RevenueValueIndustryS&P 500US Markets
8.13M
0.09
1.30
7.27
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.07-0.11-57.14
Q03 2020--0.11-
Q02 2020--0.17-
Q01 2020--0.28-
Q04 2019--0.26-
Q03 2019--0.19-
Q02 2019--0.22-
Q01 2019--0.19-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.0918.18Positive
6/2021 QR-0.0918.18Positive
12/2021 FY-0.416.82Positive
12/2022 FY-0.4320.37Positive
Next Report Date11th May 2021
Estimated EPS Next Report-0.09
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1.77M
Shares Outstanding91.52M
Trades Count14.28K
Dollar Volume11.27M
Avg. Volume2.08M
Avg. Weekly Volume1.24M
Avg. Monthly Volume2.39M
Avg. Quarterly Volume2.02M

Curis Inc. (NASDAQ: CRIS) stock closed at 10.82 per share at the end of the most recent trading day (a -5.91% change compared to the prior day closing price) with a volume of 1.75M shares and market capitalization of 1.04B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 28 people. Curis Inc. CEO is James E. Dentzer.

The one-year performance of Curis Inc. stock is 1594.03%, while year-to-date (YTD) performance is 32.11%. CRIS stock has a five-year performance of 22.95%. Its 52-week range is between 0.68 and 13.44, which gives CRIS stock a 52-week price range ratio of 83.78%

Curis Inc. currently has a PE ratio of -18.20, a price-to-book (PB) ratio of 8.28, a price-to-sale (PS) ratio of 129.52, a price to cashflow ratio of 36.40, a PEG ratio of 2.32, a ROA of -24.66%, a ROC of -10.67% and a ROE of -63.80%. The company’s profit margin is -%, its EBITDA margin is -227.70%, and its revenue ttm is $8.13 Million , which makes it $0.09 revenue per share.

Of the last four earnings reports from Curis Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.09 for the next earnings report. Curis Inc.’s next earnings report date is 11th May 2021.

The consensus rating of Wall Street analysts for Curis Inc. is (0), with a target price of $13.75, which is +20.93% compared to the current price. The earnings rating for Curis Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Curis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Curis Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.90, ATR14 : 0.93, CCI20 : -99.34, Chaikin Money Flow : 0.16, MACD : -0.03, Money Flow Index : 60.59, ROC : 4.95, RSI : 43.02, STOCH (14,3) : 25.79, STOCH RSI : 0.22, UO : 52.69, Williams %R : -74.21), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Curis Inc. in the last 12-months were: James E. Dentzer (Sold 5 377 shares of value $57 780 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

CEO: James E. Dentzer

Telephone: +1 617 503-6500

Address: 4 Maguire Road, Lexington 02421, MA, US

Number of employees: 28

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

53%47%

Bearish Bullish

60%40%

News

Stocktwits